Cargando…
Immunoprotection against Cryptococcosis Offered by Znf2 Depends on Capsule and the Hyphal Morphology
Systemic cryptococcosis is fatal without treatment. Globally, this disease kills 180,000 of the 225,000 infected people each year, even with the use of antifungal therapies. Currently, there is no vaccine to prevent cryptococcosis. Previously, we discovered that Znf2, a morphogenesis regulator that...
Autores principales: | Lin, Jianfeng, Pham, Tuyetnhu, Hipsher, Kenton, Glueck, Nathan, Fan, Yumeng, Lin, Xiaorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749420/ https://www.ncbi.nlm.nih.gov/pubmed/35012334 http://dx.doi.org/10.1128/mbio.02785-21 |
Ejemplares similares
-
Vaccination with a ZNF2(oe) Strain of Cryptococcus Provides Long-Lasting Protection against Cryptococcosis and Is Effective in Immunocompromised Hosts
por: Pham, Tuyetnhu, et al.
Publicado: (2023) -
Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis
por: Ambati, Suresh, et al.
Publicado: (2021) -
The RAM signaling pathway links morphology, thermotolerance, and CO(2) tolerance in the global fungal pathogen Cryptococcus neoformans
por: Chadwick, Benjamin J, et al.
Publicado: (2022) -
Identification and Characterization of an Intergenic “Safe Haven” Region in Human Fungal Pathogen Cryptococcus gattii
por: Li, Yeqi, et al.
Publicado: (2022) -
A Case of Pulmonary Cryptococcosis by Capsule-deficient Cryptococcus neoformans
por: Cheon, Won Seok, et al.
Publicado: (2006)